Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지

Breast Cancer Screening Among Females in Iran and Recommendations for Improved Practice: A Review

Babu, Giridhara R;Samari, Goleen;Cohen, Sharon Phoebe;Mahapatra, Tanmay;Wahbe, Randa May;Mermash, Sherin;Galal, Osman M

  • Published : 20110700
⟨ Previous Next ⟩

Abstract

Breast cancer is the second most common cancer amongst women, in Iran comprising 21.4% of female cancers. There are several screening modalities for breast cancer including breast self-examination, clinical breast examination and mammography. This research reviews the literature surrounding the implementation of these screening approaches in the Islamic Republic of Iran. After initial results produced approximately 208 articles, a total of 96 articles were included because they specifically addressed epidemiological characteristics of breast cancer, culture, religion, health seeking behavior, screening programs and the health system in Iran. Literature showed that breast self-examination and clinical breast examination were most common as there is no population-based mammography screening program in Iran. Additionally, most women appear to obtain information through the mass media. Results also indicate that Islamic beliefs and preventative medicine are very much aligned and can be used to promote breast cancer screening in Iran. These results highlight that there is a need for aggressive preventative measures focusing on breast self examination and gradually moving towards national mammography programs in Iran ideally disseminated through the media with government support.

Keywords

References

  1. Abbasi S (2010). Estrogen receptor-beta gene polymorphism in women with breast cancer at the Imam Khomeini Hospital Complex, Iran. BMC Med Genet, 11, 109.
  2. Anderson WF, Chatterjee N, Ershler WB, et al (2002). Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat, 76, 27-36. https://doi.org/10.1023/A:1020299707510
  3. Anderson WF (2003). Puberty and genetic susceptibility to breast cancer. N Engl J Med, 349, 1088-9. https://doi.org/10.1056/NEJM200309113491116
  4. Asadi-Lari M, Sayyarri AA, Akbari ME, et al (2004). Public health improvement in Iran-lessons from the last 20 years. J Royal Inst Public Health, 118, 395-402.
  5. Babu GR (2009). Comment on "Development and Validation of a Colon Cancer Risk Assessment Tool for Patients Undergoing Colonoscopy". Am J Gastroenterol, 104, 3102-3, 487.
  6. Babu GR (2009). Response to 'Cancer incidence rates among South Asians in four geographic regions, India, Singapore, UK and US'. Int J Epidemiol, 38, 1157-8. https://doi.org/10.1093/ije/dyn119
  7. Baxter N (2001). Preventive health care, 2001 update, should women be routinely taught breast self-examination to screen for breast cancer? CMAJ, 164, 1837-46.
  8. Bidgoli SA, Ahmadi R, Zavarhei MD (2010). Role of hormonal and environmental factors on early incidence of breast cancer in Iran. Sci Total Environ, 408, 4056-61. https://doi.org/10.1016/j.scitotenv.2010.05.018
  9. Choudhry UK, Srivastava R, Fitch MI (1998). Breast cancer detection practices of south Asian women, knowledge, attitudes, and beliefs. Oncol Nurs Forum, 25,1693-1701.
  10. Couper I (2004). Rural Primary Health Care in Iran. Rural Health Issues.
  11. De Waar, De LJ, Baanders-Van Halewijn EA (1960). On the bimodal age distribution of mammary carcinoma. Br J Cancer, 14, 437-48. https://doi.org/10.1038/bjc.1960.47
  12. Ebrahimi M, Vahdaninia M, Montazeri A (2002). Risk factors for breast cancer in Iran, a case-control study. Breast Cancer Res, 4, 10. https://doi.org/10.1186/bcr465
  13. Elmore JG, Armstrong K, Lehman CD, et al (2005). Screening for breast cancer. JAMA , 293, 1245-56. https://doi.org/10.1001/jama.293.10.1245
  14. Erdbrink T (2009). Iran Blocks Facebook, Outlet for opposition, The Washington Post, 5-25-2009. Ref Type, Online Source
  15. Ershler WB (1994). A Gerontologist's Perspective on Cancer Biology and Treatment. Cancer Control, 1,103-7.
  16. Faghih Z, Erfani N, Razmkhah M, et al (2009). Interleukin13 haplotypes and susceptibility of Iranian women to breast cancer. Mol Biol Rep, 36, 1923-8. https://doi.org/10.1007/s11033-008-9400-7
  17. Fallahazad V, Kamalian N, Gransar A (2004). The prevalence of estrogen and progesterone receptors in Breast Cancer in Shariati general hospital of Tehran 2000-2002. J Tehran Med Faculty, 62, 745-8.
  18. Family Protection Draft Bill (2007). Women's field ( 2009 (cited 2009 May 11), Available from, URL,http,//www.meydaan. net/errors.htm?aspxerrorpath=/English/ShowArticle.aspx
  19. Fletcher SW, Elmore JG (2003). Clinical practice. Mammographic screening for breast cancer. N Engl J Med, 348,1672-80. https://doi.org/10.1056/NEJMcp021804
  20. Fung SY (1998). Factors associated with breast self-examination behaviour among Chinese women in Hong Kong. Patient Education and Counselling, 33, 233-43. https://doi.org/10.1016/S0738-3991(98)00023-8
  21. Haji-Mahmoodi M, Montazeri A, Jarvandi S, et al (2002). Breast self-examination, knowledge, attitudes, and practices among female health care workers in Tehran, Iran. Breast J , 8, 222-5. https://doi.org/10.1046/j.1524-4741.2002.08406.x
  22. Hajian-Tilaki KO, Gholizadehpasha AR, Bozorgzadeh S, et al (2010). Body mass index and waist circumference are predictor biomarkers of breast cancer risk in Iranian women. Med Oncol.
  23. Hajian-Tilaki KO, Kaveh-Ahangar T (2010). Reproductive factors associated with breast cancer risk in northern Iran. Med Oncol.
  24. Harandy TF, Ghofranipour F, Montazeri A, et al (2010). Muslim breast cancer survivor spirituality, coping strategy or health seeking behavior hindrance? Health Care Women Int, 31, 88-98.
  25. Harirchi I, Ebrahimi M, Zamani N, et al (2000). Breast cancer in Iran, a review of 903 case records. Public Health, 114, 143-5.
  26. Harirchi I, Ghaemmaghami F, Karbakhsh M, et al (2005). Patient delay in women presenting with advanced breast cancer, an Iranian study. Public Health, 119, 885-91. https://doi.org/10.1016/j.puhe.2004.11.005
  27. Harirchi I, Karbakhsh M, Montazeri A, et al (2010). Decreasing trend of tumor size and downstaging in breast cancer in Iran, results of a 15-year study. Eur J Cancer Prev 2010, 19, 126-30. https://doi.org/10.1097/CEJ.0b013e328333d0b3
  28. Harirchi I, Kolahdoozan S, Karbakhsh M, et al (2010). Twenty years of breast cancer in Iran, downstaging without a formal screening program. Ann Oncol. https://doi.org/10.1093/annonc/mdq303
  29. Harirchi I, Mousavi SM, Mohagheghi MA, et al (2009). Early detection for breast cancer in iran. Asian Pac J Cancer Prev 2009, 10, 849-51.
  30. Harrison GG, Galal OM (2004). Medicine. Encyclopedia of Islam and Muslim world, Macmillan references, USA.
  31. Hashemian AH, Hajizadeh E, Kazemnejad A, et al (2009). Penetrance of BRCA1/BRCA2 specific gene mutations in Iranian women with breast cancer. Saudi Med J, 30, 41-4.
  32. Hisham AN, Yip CH (2003). Spectrum of breast cancer in Malaysian women, overview. World J Surg, 27, 921-3. https://doi.org/10.1007/s00268-003-6976-x
  33. Hosseinpoor AR, Naghavi M, Alavian SM, et al (2007). Determinants of seeking needed outpatient care in Iran, results from a national health services utilization survey. Arch Iran Med, 10, 439-45.
  34. Iran's Health Ministry Releases Figures on HIV/AIDS cases (2009). Medical News Today, 5-11-2009. Ref Type, Online Source.
  35. Jarvandi S, Montazeri A, Harirchi I, et al (2002). Beliefs and behaviours of Iranian teachers toward early detection of breast cancer and breast self-examination. Public Health 2002, 116, 245-9. https://doi.org/10.1038/sj.ph.1900854
  36. Kashfi F, Nikou FA, Mohammadi R (2002). Fertility risk factors causing breast cancer. Medical journal of reproduction and infertility, 3, 38-45.
  37. Khalili-Azad T, Razmkhah M, Ghiam AF (2009). Association of interleukin-18 gene promoter polymorphisms with breast cancer. Neoplasma, 56, 22-5. https://doi.org/10.4149/neo_2009_01_22
  38. Kolahdoozan S, Sadjadi A, Radmard AR (2010). Five common cancers in Iran. Arch Iran Med, 13, 143-6.
  39. Lamyian M, Hydarnia A, Ahmadi F, et al (2007). Barriers to and factors facilitating breast cancer screening among Iranian women, a qualitative study. East Mediterr Health J, 13, 1160-9. https://doi.org/10.26719/2007.13.5.1160
  40. Lancet (1999). 16-year mortality from breast cancer in the UK. Trial of Early Detection of Breast Cancer, 353, 1909-14.
  41. Lebaron SW, Schultz SH (2005). Family medicine in Iran, the birth of a new specialty. Fam Med, 37, 502-5.
  42. Lindberg NM, Stevens VJ, Smith KS, et al (2009). A brief intervention designed to increase breast cancer selfscreening. Am J Health Promot 2009, 23, 320-3. https://doi.org/10.4278/ajhp.071009106
  43. Madan AK, Barden CB, Beech B, et al (2000). Socioeconomic Factors, not Ethnicity, Predict Breast Self-Examination. Breast J, 6, 263-6. https://doi.org/10.1046/j.1524-4741.2000.99016.x
  44. Mahouri K, Dehghani ZM, Zare S (2007). Breast cancer risk factors in south of Islamic Republic of Iran, a case-control study. East Mediterr Health J, 13, 1265-73. https://doi.org/10.26719/2007.13.6.1265
  45. Marjani A, Kabir MJ (2009). Breast cancer incidence among females in the Golestan province, Iran. Indian J Cancer, 46, 351-2. https://doi.org/10.4103/0019-509X.55564
  46. Mehdipour P, Pirouzpanah S, Sarafnejad A, et al (2009). Prognostic implication of CDC25A and cyclin E expression on primary breast cancer patients. Cell Biol Int, 33, 1050-6. https://doi.org/10.1016/j.cellbi.2009.06.016
  47. Montazeri A, Haghighat S, Vahdani M, et al (1999). Evaluation of a national breast cancer information service, the Iranian experience. Support Care Cancer, 7, 154-7. https://doi.org/10.1007/s005200050246
  48. Montazeri A, Haji-Mahmoodi M, Jarvandi S (2003). Breast self-examination, do religious beliefs matter? A descriptive study. J Public Health Med, 25, 154-5. https://doi.org/10.1093/pubmed/fdg031
  49. Montazeri A, Sadighi J, Farzadi F, et al (2008). Weight, height, body mass index and risk of breast cancer in postmenopausal women, a case-control study. BMC Cancer, 8, 278. https://doi.org/10.1186/1471-2407-8-278
  50. Montazeri A, Vahdaninia M, Harirchi I, et al (2008). Breast cancer in Iran, need for greater women awareness of warning signs and effective screening methods. Asia Pac Fam Med, 7, 6. https://doi.org/10.1186/1447-056X-7-6
  51. Moolgavkar SH, Lee JA, Hade RD (1978). Comparison of agespecific mortality from breast cancer in males in the United States and Japan. J Natl Cancer Inst, 60, 1223-5. https://doi.org/10.1093/jnci/60.6.1223
  52. Motamed N, Hadi N, Talei A (2004). A survey on risk factors of breast cancer in women over 35 years of age. Journal of Zanjan University of Medical Sciences and health services, 12, 25-32.
  53. Motovali-Bashi M, Sadeghi M, Hemmati S (2010). Serum MMP-9 level associated with initiation and progression steps of breast cancer in the Iranian population. Reprod Sci, 17, 585-9. https://doi.org/10.1177/1933719110364418
  54. Mousavi SM, Alamolhoda AA, Gouya MM, et al (2008). Implementation of Comprehensive National Cancer Control Program in Iran, an experience in a developing country. Ann Oncol, 19, 398-400.
  55. Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
  56. Mousavi SM, Harirchi I, Ebrahimi M, et al (2008). Screening for breast cancer in Iran, a challenge for health policy makers. Breast J 2008, 14, 605-6. https://doi.org/10.1111/j.1524-4741.2008.00662.x
  57. Mousavi SM, Mohagheghi MA, Mousavi-Jerrahi A, et al (2008). Outcome of breast cancer in Iran, a study of Tehran Cancer Registry data. Asian Pac J Cancer Prev, 9, 275-8.
  58. Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast cancer in Iran, an epidemiological review. Breast J 2007, 13, 383-91. https://doi.org/10.1111/j.1524-4741.2007.00446.x
  59. Nikseresht M, Seghatoleslam A, Monabati A, et al (2010). Overexpression of the novel human gene, UBE2Q2, in breast cancer. Cancer Genet Cytogenet 2010, 197, 101-6. https://doi.org/10.1016/j.cancergencyto.2009.11.020
  60. Noroozi A, Jomand T, Tahmasebi R (2010). Determinants of Breast Self-Examination Performance Among Iranian Women, An Application of the Health Belief Model. J Cancer Educ. https://doi.org/10.1007/s13187-010-0158-y
  61. O'Connor KM (1999). Prophetic medicine and Qur'anic healing, Religious healing systems in Islam, Essays in Middle Eastern Health.
  62. Oran B, Celik I, Erman M, et al (2004). Analysis of menstrual, reproductive, and life-style factors for breast cancer risk in Turkish women, a case-control study. Med Oncol, 21, 31-40. https://doi.org/10.1385/MO:21:1:31
  63. Parkin DM, Bray F, Ferlay J, et al (2001). Pisani P. Estimating the world cancer burden, Globocan 2000. Int J Cancer, 94, 153-6. https://doi.org/10.1002/ijc.1440
  64. Parkin DM, Bray F, Ferlay J, et al (2002). CA Cancer J Clin 2005. 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  65. Parkin DM, Bray FI, Devesa SS (2001). Cancer burden in the year 2000. The global picture. Eur J Cancer, 37, S4-66.
  66. Perou CM, Sorlie T, Eisen MB, et al (2000). Molecular portraits of human breast tumours. Nature, 406, 747-52. https://doi.org/10.1038/35021093
  67. Persson K, Svensson PG, Ek AC (1997). Breast self-examination, an analysis of self-reported practice. J Adv Nurs, 25, 886-92. https://doi.org/10.1046/j.1365-2648.1997.1997025886.x
  68. Pessaran Z, Rezaei A, Siadat AH, et al (2003). Evaluation of breast cancer risk factors for using in hormone replacement therapy of corticosteroid-treated post-menopausal women. Shahrekord University of Medical Sciences journal, 2, 70-5.
  69. Petro-Nustus W, Mikhail BI (2002). Factors associated with breast self-examination among jordanian women. Public Health Nurs, 19, 263-71. https://doi.org/10.1046/j.1525-1446.2002.19406.x
  70. Medical News Today (2009). Physicians Who Addressed HIV/AIDS in Iran Convicted of Plot to Overthrow Iranian Government. Medical News Today.2009. 2009. 5-11-2009.
  71. Pirouzpanah S, Taleban FA, Atri M, et al (2010). The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer. Cancer Causes Control. https://doi.org/10.1007/s10552-010-9629-z
  72. Rasti M, Tavasoli P, Monabati A, et al (2009). Association between HIC1 and RASSF1A promoter hypermethylation with MTHFD1 G1958A polymorphism and clinicopathological features of breast cancer in Iranian patients. Iran Biomed J, 13, 199-206.
  73. Report on the Status of Internet in Iran (2005). Iran CSOs Training and Research Center. 5-15-2009.
  74. Reporters Without Borders (2004). Country Profile, Iran. 5-11- 2009. Ref Type, Online Source
  75. Rezaianzadeh A, Peacock J, Reidpath D, et al (2009). Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran. BMC Cancer 2009, 9, 168. https://doi.org/10.1186/1471-2407-9-168
  76. Sadjadi A, Hislop TG, Bajdik C, et al (2009). Comparison of breast cancer survival in two populations, Ardabil, Iran and British Columbia, Canada. BMC Cancer 2009, 9, 381. https://doi.org/10.1186/1471-2407-9-381
  77. Semiglazov VF, Moiseyenko VM, Bavli JL, et al (1992). The role of breast self-examination in early breast cancer detection (results of the 5-years USSR/WHO randomized study in Leningrad). Eur J Epidemiol, 8, 498-502. https://doi.org/10.1007/BF00146366
  78. Semiglazov VF, Sagaidak VN, Moiseyenko VM, et al (1993). Study of the role of breast self-examination in the reduction of mortality from breast cancer, The Russian Federation/ World Health Organization Study. Eur J Cancer, 29, 2039- 46. https://doi.org/10.1016/0959-8049(93)90468-U
  79. Sharif F, Abshorshori N, Tahmasebi S, et al (2010). The effect of peer-led education on the life quality of mastectomy patients referred to breast cancer-clinics in Shiraz, Iran. Health Qual Life Outcomes, 8, 74. https://doi.org/10.1186/1477-7525-8-74
  80. Simi A, Yadollahie M, Habibzadeh F (2009). Knowledge and attitudes of breast self examination in a group of women in Shiraz, southern Iran. Postgrad Med J, 85, 283-7. https://doi.org/10.1136/pgmj.2008.072678
  81. Somi MH, Farhang S, Mirinezhad SK, et al (2008). Cancer in East Azerbaijan, Iran, results of a population-based cancer registry. Asian Pac J Cancer Prev, 9, 327-30.
  82. Spratt JS, Jr., Kaltenbach ML, Spratt JA (1977). Cytokinetic definition of acute and chronic breast cancer. Cancer Res, 37, 226-30.
  83. Stevens RG, Moolgavkar SH, Lee JA (1982). Temporal trends in breast cancer. Am J Epidemiol, 115, 759-77. https://doi.org/10.1093/oxfordjournals.aje.a113358
  84. Tarone RE, Chu KC (2002). The greater impact of menopause on ER- than ER+ breast cancer incidence, a possible explanation (United States). Cancer Causes Control, 13,7-14. https://doi.org/10.1023/A:1013960609008
  85. Tavafian SS, Hasani L, Aghamolaei T, et al (2009). Prediction of breast self-examination in a sample of Iranian women, an application of the Health Belief Model. BMC Womens Health, 9, 37. https://doi.org/10.1186/1472-6874-9-37
  86. Taymoori P, Berry T (2009). The validity and reliability of Champion's Health Belief Model Scale for breast cancer screening behaviors among Iranian women. Cancer Nurs, 32, 465-72. https://doi.org/10.1097/NCC.0b013e3181aaf124
  87. Thomas DB, Gao DL, Self SG, et al (1997). Randomized trial of breast self-examination in Shanghai, methodology and preliminary results. J Natl Cancer Inst, 89, 355-65. https://doi.org/10.1093/jnci/89.5.355
  88. Underwood SM, Shaikha L, Bakr D (1999). Veiled yet vulnerable. Breast cancer screening and the Muslim way of life. Cancer Pract, 7, 285-90. https://doi.org/10.1046/j.1523-5394.1999.76004.x
  89. UNICEF, UNICEF Country Profile (2004). At a Glance, Islamic Republic of Iran. UNICEF Country Profile.
  90. Usher S. Iran's leaders harness media power, BBC News, 2006.
  91. Vallian S, Sedaghat M, Nassiri I, et al (2009). Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer. J Cancer Res Clin Oncol, 135, 991-6. https://doi.org/10.1007/s00432-008-0534-8
  92. Women's Forum Against Fundamentalism in Iran (2005). Official laws against women in Iran, available from URL http,//www.wfafi.org/laws.pdf
  93. Yasui Y, Potter JD (1999). The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control, 10, 431-7. https://doi.org/10.1023/A:1008970121595
  94. Yavari P, Abadi A, Mehrabi Y (2003). Mortality and changing epidemiological trends in Iran during 1979-2001. Hakim research journal, 6, 7-14.
  95. Yavari P, Hislop TG, Abanto G (2005). Methodology to identify Iranian immigrants for epidemiological studies. Asian Pac J Cancer Prev, 6, 455-7.
  96. WHO (2002). World Health Organization, Epidemiology of breast cancer in Iran.
  97. WHO (2009). Epidemiology of breast cancer in the Islamic Republic of Iran, first results from a population-based cancer registry. East Mediterr Health J, 15, 1426-31.